Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options Biotech Investing
Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference Biotech Investing
Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma Biotech Investing
HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Biotech Investing
